77529397 - GENEART THE PROTEIN OF YOUR CHOICE

Information

  • Trademark
  • 77529397
  • Serial Number
    77529397
  • Registration Number
    3717457
  • Filing Date
    July 23, 2008
    16 years ago
  • Registration Date
    December 01, 2009
    15 years ago
  • Transaction Date
    July 24, 2014
    10 years ago
  • Status Date
    December 01, 2009
    15 years ago
  • Published for Opposition Date
    September 15, 2009
    15 years ago
  • Location Date
    December 01, 2009
    15 years ago
  • Status Code
    700
  • Current Location
    PUBLICATION AND ISSUE SECTION
    Employee Name
    MITTLER, ROBIN M
  • Attorney Name
    Phil Makrogiannis
    Law Office Assigned Location Code
    M80
  • Owners
Mark Drawing Code
3000
Mark Identification
GENEART THE PROTEIN OF YOUR CHOICE
Case File Statements
  • CC0000: The color(s) blue and orange is/are claimed as a feature of the mark.
  • DM0000: The mark consists of four blue horizontal lines attached to the orange letter "G" followed by the orange letters "ENE" and the blue letters "ART", all on top of the phrase "the protein of your choice" written in blue.
  • GS0011: Chemical preparations for scientific purposes, namely, for laboratory analysis in the field of biotechnology, drug discovery, genomics, molecular, biology and microbiology; chemical preparations for scientific purposes in the field of biotechnology, drug discovery, genomics, molecular biology and microbiology; bacteria preparations for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; bacteriological preparations for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; microorganism cultures for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biochemical catalysts for use in food manufacture, waste water treatment, fermentation, research, manufacture of cosmetics, manufacture of scientific compounds, manufacture of pharmaceutical compounds; biological materials for clinical, scientific, research and medical laboratories, namely, proteins, DNA, RNA and modifications thereof; diagnostic materials for clinical, scientific, research and medical laboratory purposes, namely, proteins, DNA, RNA and modifications thereof; enzymes and enzyme preparations for use in the field of food manufacture, waste treatment, fermentation, manufacture of cosmetics, manufacture of scientific compounds, and manufacture of pharmaceutical compounds; biological materials for medical diagnostic laboratory use, namely, proteins, DNA, RNA and modifications thereof; diagnostic materials for clinical and medical laboratory purposes, namely, proteins, DNA, RNA and modifications thereof; deoxyribonucleic acid, namely, deoxyribonucleic acid comprising 80 to 150 base pairs for scientific and research purposes; and genes, namely, genes comprising 80 to 150 base pairs for scientific and research purposes
  • GS0051: Medicines for human-medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; medicines for dental purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, Alzheimer's and infectious diseases; medicines for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; bacteriological preparations for medical and veterinary purposes for use in the treatment of cancer, high blood pressure, diarrhea, skin irritations, infections, diabetes, autoimmune diseases and arthritis as well as for use in gene therapy; biological preparations for medical purposes, namely, antibiotics, antibodies, DNA, RNA, vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; biological preparations for veterinary purposes, namely, antibiotics, antibodies, DNA, RNA, Vaccines, blood-producing preparations, hormones and enzymes for use in the treatment of cancer, diabetes, Alzheimer's and infectious diseases; germicides for medical and laboratory equipment and for institutional and domestic uses; vermicides for medical and laboratory equipment and for institutional, domestic, and residential uses; fungicides for medical and laboratory equipment and for institutional and domestic uses; deoxyribonucleic acid, namely, deoxyribonucleic acid comprising 80 to 150 base pairs for diagnostic medical purposes; and genes, namely, genes comprising 80 to 150 base pairs for medical diagnostic purposes
  • GS0071: Filling machines; machine parts, namely, machine housings; membranes specially designed for electric pumps; mixers; pumps, namely, electric pumps; regulators being parts of machines; industrial robots; separators, namely, centrifugal separators
  • GS0091: Scientific and laboratory equipment, namely, automatic machines for the synthesis of deoxyribonucleinic acids; robot machines for laboratory purposes; computer terminals; computer programs for use as tools for design and synthesis of deoxyribonucleic acids, genes and proteins; computer software to increase potency of enzymes and enzyme preparations, bacteria preparations, bacteriological preparations, micro-organism cultures, biological preparations and diagnostic preparations; computer operating programs; computer peripheral devices; computer keyboards; blank magnetic data carriers; blank optical disks; data processing apparatus, namely, data processors; computer memories; blank floppy computer disks; blank hard drives for computers; printers for use with computers; computer interfaces; laptop computers; data processors, namely, readers and scanners; computer mouse; microprocessors in the nature of semiconductors; computer modems; computer monitors; computer hardware; and notebook computers
  • GS0421: Computer services, namely, updating of computer software for others, consulting in the field of biotechnology, designing computer software for others, maintenance of computer software for others, rental of computer software, computer programming for others, leasing of computers, and reconstruction of computer data for others; chemical analysis for others; research for others in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics, genetic engineering, and machine engineering; medical laboratory services for others in the fields of bacteriology and chemistry; consultation in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics research, engineering and machine engineering; consultation in the field of pharmacology; measuring calibration for others; development and research of new products for others; technical consultation in the field of environmental protection; technical project planning and technology consulting services in the fields of bacteriology, biology, chemistry, physics, genealogy, cosmetics research, engineering, and machine engineering; and quality control for others
  • PM0001: GENE ART THE PROTEIN OF YOUR CHOICE
Case File Event Statements
  • 7/23/2014 - 10 years ago
    28 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA
  • 7/23/2014 - 10 years ago
    27 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP
  • 10/21/2011 - 13 years ago
    26 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA
  • 10/21/2011 - 13 years ago
    25 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP
  • 8/2/2011 - 13 years ago
    24 - ATTORNEY REVOKED AND/OR APPOINTED Type: ARAA
  • 8/2/2011 - 13 years ago
    23 - TEAS REVOKE/APPOINT ATTORNEY RECEIVED Type: REAP
  • 2/1/2011 - 13 years ago
    22 - TEAS CHANGE OF CORRESPONDENCE RECEIVED Type: TCCA
  • 12/1/2009 - 15 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 9/15/2009 - 15 years ago
    20 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 8/26/2009 - 15 years ago
    19 - NOTICE OF PUBLICATION Type: NPUB
  • 8/11/2009 - 15 years ago
    18 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 8/7/2009 - 15 years ago
    17 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 7/22/2009 - 15 years ago
    16 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 7/22/2009 - 15 years ago
    15 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 7/20/2009 - 15 years ago
    14 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 4/14/2009 - 15 years ago
    13 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 4/14/2009 - 15 years ago
    12 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 4/14/2009 - 15 years ago
    11 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 3/24/2009 - 15 years ago
    10 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 3/24/2009 - 15 years ago
    9 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 3/23/2009 - 15 years ago
    8 - ASSIGNED TO LIE Type: ALIE
  • 3/23/2009 - 15 years ago
    7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 9/23/2008 - 16 years ago
    6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED Type: GNRN
  • 9/23/2008 - 16 years ago
    5 - NON-FINAL ACTION E-MAILED Type: GNRT
  • 9/23/2008 - 16 years ago
    4 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 9/19/2008 - 16 years ago
    3 - ASSIGNED TO EXAMINER Type: DOCK
  • 7/29/2008 - 16 years ago
    2 - NOTICE OF DESIGN SEARCH CODE MAILED Type: MDSC
  • 7/28/2008 - 16 years ago
    1 - NEW APPLICATION ENTERED IN TRAM Type: NWAP